Global Facial Injectable Market 2011-2015Published by: Infiniti Research Limited Published: Feb. 21, 2012 - 36 Pages Table of Contents
AbstractTechNavio’s analysts forecast the Global Facial Injectable market to grow at a CAGR of 8.5 percent over the period 2011–2015. One of the key factors contributing to this market growth is increasing incidents of HIV-associated Lipodystrophy in the US. The Global Facial Injectable market has also been witnessing an increase in new product launches. However, side effects of dermal fillers could pose a challenge to the growth of this market.TechNavio’s report, Global Facial Injectable Market 2011–2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Facial Injectable market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors dominating this market space include Allergan Inc., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Ipsen S.A., and Sanofi S.A. Key questions answered in this report:
Get full details about this report >> |
|
|
|
About MarketResearch.com
|
||

